Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Leveraging Momentum of the America First Global Health Strategy with the Signing of the United States–Liberia Bilateral Health Cooperation Memorandum of Understanding - United States Department of State